Omics in Myopia
Emil Tomasz Grochowski, Karolina Pietrowska, Tomasz Kowalczyk, Zofia Mariak, Adam Krętowski, Michał Ciborowski, Diana Anna Dmuchowska
Abstract
Myopia is a globally emerging issue, with multiple medical and socio-economic burdens and no well-established causal treatment thus far. A better insight into altered biochemical pathways and underlying pathogenesis might facilitate early diagnosis and treatment of myopia, ultimately leading to the development of more effective preventive and therapeutic measures. In this review, we summarize current data about the metabolomics and proteomics of myopia in humans and present various experimental approaches and animal models, along with their strengths and weaknesses. We also discuss the potential applicability of these findings to medical practice and suggest directions for future research.